NYSE:NBY

Novabay Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy NBY

*Your capital is at risk

$1.47

+0 (+0%)

At Close: Jun 03, 2026

NovaBay Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 344.64M and sold 441.33K NBY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	344.64M shares
● Sell	441.33K shares
99% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence May 21, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 100. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 21, 2025 Buy	Common Stock A-Award	Lazar David E. 10 Percent Owner	10% Owner	6 388 000 Value: $37.1M
Oct 21, 2025 Buy	Series D Convertible Preferred Stock M-Exempt	Lazar David E. 10 Percent Owner	10% Owner	39 925 Value: $231.6K
Oct 21, 2025 Buy	Common Stock C-Conversion	Kazley Michael John Chief Executive Officer	CEO / President	56 806 080 Value: $0.33B
Oct 21, 2025 Buy	Common Stock C-Conversion	R01 Fund Lp 10 Percent Owner	10% Owner	56 806 080 Value: $0.33B
Oct 21, 2025 Buy	Common Stock C-Conversion	Framework Ventures Iv L.p. 10 Percent Owner	10% Owner	56 806 080 Value: $0.33B
Oct 16, 2025 Buy	Pre-Funded Warrants (Right to Buy) P-Purchase	Kazley Michael John Chief Executive Officer	CEO / President	2 702 703 Value: $27.0K
Oct 16, 2025 Buy	Pre-Funded Warrants (Right to Buy) P-Purchase	R01 Fund Lp 10 Percent Owner	10% Owner	2 702 703 Value: $27.0K
Oct 16, 2025 Buy	Pre-Funded Warrants (Right to Buy) P-Purchase	Framework Ventures Iv L.p. 10 Percent Owner	10% Owner	2 702 703 Value: $27.0K
Oct 16, 2025 Buy	Series E Non-Voting Convertible Preferred Stock A-Award	Kazley Michael John Chief Executive Officer	CEO / President	134 375 Value: $765.9K
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock A-Award	Kazley Michael John Chief Executive Officer	CEO / President	220 663 Value: $1.26M
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock J-Other	Framework Ventures Iv L.p. 10 Percent Owner	10% Owner	220 663 Value: $1.26M
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock	R01 Fund Lp 10 Percent Owner	10% Owner	1 164 117 Value: $6.64M
Oct 16, 2025 Buy	Series E Non-Voting Convertible Preferred Stock J-Other	Framework Ventures Iv L.p. 10 Percent Owner	10% Owner	134 375 Value: $765.9K
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock A-Award	R01 Fund Lp 10 Percent Owner	10% Owner	220 663 Value: $1.26M
Oct 16, 2025 Buy	Series E Non-Voting Convertible Preferred Stock A-Award	R01 Fund Lp 10 Percent Owner	10% Owner	134 375 Value: $765.9K
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock	Kazley Michael John Chief Executive Officer	CEO / President	1 164 117 Value: $6.64M
Oct 16, 2025 Buy	Series D Non-Voting Convertible Preferred Stock	Framework Ventures Iv L.p. 10 Percent Owner	10% Owner	1 164 117 Value: $6.64M
Oct 16, 2025 Sell	Series D Convertible Preferred Stock S-Sale	Lazar David E. 10 Percent Owner	10% Owner	441 325 Value: $0
Aug 19, 2025 Buy	Common Stock	Lazar David E. Chief Executive Officer	CEO / President	0 Value: $0
Aug 19, 2025 Buy	Series D Convertible Preferred Stock	Lazar David E. Chief Executive Officer	CEO / President	77 000 000 Value: $0.23B
Aug 19, 2025 Buy	Series D Convertible Preferred Stock	Lazar David E. Chief Executive Officer	CEO / President	77 000 000 Value: $0.23B
Aug 19, 2025 Buy	Common Stock	Lazar David E. Chief Executive Officer	CEO / President	0 Value: $0
Apr 08, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	300 Value: $140
Apr 08, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	300 Value: $140
Apr 04, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	4 538 Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVABAY PHARMACEUTICALS, INC

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising ...

Read Full Profile Here